Hepatic and hippocampal cytochrome P450 enzyme overexpression during spontaneous recurrent seizures

被引:22
|
作者
Runtz, Leonie [1 ]
Girard, Benoit [2 ]
Toussenot, Marion [1 ]
Espallergues, Julie [3 ]
De Maudave, Alexis Fayd'Herbe [1 ]
Milman, Alexandre [4 ]
deBock, Frederic [1 ]
Ghosh, Chaitali [5 ]
Guerineau, Nathalie C. [4 ]
Pascussi, Jean-Marc [6 ]
Bertaso, Federica [2 ]
Marchi, Nicola [1 ]
机构
[1] CNRS, Inst Funct Genom, Lab Cerebrovasc Mech Brain Disorders, UMR 5203,U1191,INSERM, Montpellier, France
[2] CNRS, Inst Funct Genom, Lab Pathophysiol Synapt Transmiss, UMR 5203,U1191,INSERM, Montpellier, France
[3] Histalim, Montpellier, France
[4] CNRS, Inst Funct Genom, Ion Channels Neuronal Excitabil & Dis, UMR 5203,U1191,INSERM, Montpellier, France
[5] Cleveland Clin, Cerebrovasc Res, Cleveland, OH 44106 USA
[6] CNRS, Lab Self Renewal & Differentiat Epithelia, Inst Funct Genom, UMR 5203,U1191,INSERM, Montpellier, France
关键词
inflammation; drug metabolism; epilepsy; liver; P450; BLOOD-BRAIN-BARRIER; XENOBIOTIC RECEPTORS; ABC TRANSPORTERS; MOUSE MODEL; EXPRESSION; NUCLEAR; INDUCTION; CORTISOL; STRESS; P450;
D O I
10.1111/epi.13942
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
ObjectiveAvailable evidence points to a role of cytochrome P450 (Cyp) drug biotransformation enzymes in central nervous system diseases, including epilepsy. Deviations in drug pharmacokinetic profiles may impact therapeutic outcomes. Here, we ask whether spontaneous recurrent seizure (SRS) activity is sufficient to modulate the expression of major Cyp enzymes in the liver and brain. MethodsUnilateral intrahippocampal (IH) kainic acid (KA) injections were used to elicit nonconvulsive status epilepticus (SE), epileptogenesis, and SRS, as monitored by video-electroencephalography. Intraperitoneal (IP) KA injection was used to trigger generalized tonic-clonic SE. KA-injected mice and sham controls were sacrificed at 24-72 hours and 1 week post-SE (IH or IP KA), and during the chronic stage (SRS; 6 weeks post-IH KA). Liver and brain tissues were processed for histology, real-time quantitative polymerase chain reaction, Western blot, or microsomal enzymatic assay. Cyp2e1, Cyp3a13, glial fibrillary acidic protein (GFAP), IBA1, xenobiotic nuclear receptors nr1i2 (PXR), nr1i3 (CAR) and nr3c1 (glucocorticoid receptor [GR]) expression was examined. Serum samples were obtained to assay corticosterone levels, a GR activator. ResultsA significant increase of Cyp3a13 and Cyp2e1 transcript level and protein expression was found in the liver and hippocampi during SRS, as compared to control mice. In the ipsilateral hippocampus, Cyp2e1 and Cyp3a protein upregulation during SRS positively correlated to GFAP expression. GFAP(+), and not IBA1(+), cells colocalized with Cyp2e1 or Cyp3a expression. In the liver, a trend increase in Cyp3a microsomal activity was found during SRS as compared to control mice. The transcript levels of the Cyp upstream regulators GR, xenobiotic nr1i2, and nr1i3 receptors were unchanged at SRS. Corticosterone levels, a GR ligand, were increased in the blood post-SE. SignificanceSRS modifies Cyp expression in the liver and the hippocampus. Nuclear receptors or inflammatory pathways are candidate mechanisms of Cyp regulation during seizures.
引用
收藏
页码:123 / 134
页数:12
相关论文
共 50 条
  • [41] Cytochrome p450 Part 2 What Nurses Need to Know About the Cytochrome p450 Family Systems
    Krau, Stephen D.
    NURSING CLINICS OF NORTH AMERICA, 2013, 48 (04) : 681 - +
  • [42] Development of an optimized procedure for the preparation of rat intestinal microsomes: comparison of hepatic and intestinal microsomal cytochrome P450 enzyme activities in two rat strains
    Bruyere, A.
    Decleves, X.
    Bouzom, F.
    Proust, L.
    Martinet, M.
    Walther, B.
    Parmentier, Y.
    XENOBIOTICA, 2009, 39 (01) : 22 - 32
  • [43] Immobilized Cytochrome P450 for Monitoring of P450-P450 Interactions and Metabolisms
    Bostick, Chris D.
    Hickey, Katherine M.
    Wollenberg, Lance A.
    Flora, Darcy R.
    Tracy, Timothy S.
    Gannett, Peter M.
    DRUG METABOLISM AND DISPOSITION, 2016, 44 (05) : 741 - 749
  • [44] Immunization and Drug Metabolizing Enzymes: Focus on Hepatic Cytochrome P450 3A
    Jonsson-Schmunk, Kristina
    Ghose, Romi
    Croyle, Maria A.
    EXPERT REVIEW OF VACCINES, 2021, 20 (05) : 623 - 634
  • [45] Normal variation of the gut microbiota affects hepatic cytochrome P450 activity in mice
    Togao, Masao
    Tajima, Shinnosuke
    Kurakawa, Takashi
    Wagai, Gaku
    Otsuka, Jun
    Kado, Shoichi
    Kawakami, Koji
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2021, 9 (06):
  • [46] Hepatic Cytochrome P450 Activity and Nitric Oxide Production During Multiple Ovalbumin Challenges
    Tanino, Tadatoshi
    Bando, Toru
    Okada, Yuna
    Nojiri, Yukie
    Hashimoto, Kanako
    Ueda, Yukari
    Sakurai, Eiichi
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2019, 44 (03) : 379 - 387
  • [47] Cytochrome P450 2C19 enzyme, Cytochrome P450 2C9 enzyme, and Cytochrome P450 2D6 enzyme allelic variants and its possible effect on drug metabolism A retrospective study
    Naujokaitis, Domas
    Asmoniene, Virginija
    Kadusevicius, Edmundas
    MEDICINE, 2021, 100 (11) : E24545
  • [48] Downregulation of Hepatic Cytochrome P450 3A in Mice Infected with Babesia microti
    Shimamoto, Yoshinori
    Sasaki, Mizuki
    Ikadai, Hiromi
    Ishizuka, Mayumi
    Yokoyama, Naoaki
    Igarashi, Ikuo
    Hoshi, Fumio
    Kitamura, Hiroshi
    JOURNAL OF VETERINARY MEDICAL SCIENCE, 2012, 74 (02) : 241 - 245
  • [49] Investigation of the effect of butyrate supplementation of the diet on hepatic cytochrome P450 enzymes in rats
    Matis Gabor
    Csiko Gyoergy
    Jemnitz Katalin
    Veres Zsuzsanna
    Febel Hedvig
    Kulcsar Anna
    Petrilla Janka
    Neogrady Zsuzsanna
    MAGYAR ALLATORVOSOK LAPJA, 2013, 135 (02) : 109 - 116
  • [50] A Minimal Functional Complex of Cytochrome P450 and FBD of Cytochrome P450 Reductase in Nanodiscs
    Prade, Elke
    Mahajan, Mukesh
    Im, Sang-Choul
    Zhang, Meng
    Gentry, Katherine A.
    Anantharamaiah, G. M.
    Waskell, Lucy
    Ramamoorthy, Ayyalusamy
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2018, 57 (28) : 8458 - 8462